Verstichel Greet, Vermijlen David, Martens Liesbet, Goetgeluk Glenn, Brouwer Margreet, Thiault Nicolas, Van Caeneghem Yasmine, De Munter Stijn, Weening Karin, Bonte Sarah, Leclercq Georges, Taghon Tom, Kerre Tessa, Saeys Yvan, Van Dorpe Jo, Cheroutre Hilde, Vandekerckhove Bart
Faculty of Medicine and Health Sciences, Department of Clinical Chemistry, Microbiology and Immunology, Ghent University, University Hospital Ghent, MRB2, De Pintelaan 185, 9000 Ghent, Belgium.
Department of Biopharmacy, Université Libre de Bruxelles (ULB), Boulevard du Triomphe, accès 2, 1050 Brussels, Belgium.
Sci Immunol. 2017 Feb 24;2(8). doi: 10.1126/sciimmunol.aah4232.
The thymus plays a central role in self-tolerance, partly by eliminating precursors with a T cell receptor (TCR) that binds strongly to self-antigens. However, the generation of self-agonist-selected lineages also relies on strong TCR signaling. How thymocytes discriminate between these opposite outcomes remains elusive. Here, we identified a human agonist-selected PD-1 CD8αα subset of mature CD8αβ T cells that displays an effector phenotype associated with agonist selection. TCR stimulation of immature post-β-selection thymocyte blasts specifically gives rise to this innate subset and fixes early T cell receptor alpha variable (TRAV) and T cell receptor alpha joining (TRAJ) rearrangements in the TCR repertoire. These findings suggest that the checkpoint for agonist selection precedes conventional selection in the human thymus.
胸腺在自身耐受中发挥核心作用,部分原因是通过清除具有与自身抗原强烈结合的T细胞受体(TCR)的前体细胞。然而,自身激动剂选择谱系的产生也依赖于强烈的TCR信号传导。胸腺细胞如何区分这些相反的结果仍然难以捉摸。在这里,我们鉴定出了成熟CD8αβ T细胞中一个人类激动剂选择的PD-1 CD8αα亚群,该亚群表现出与激动剂选择相关的效应器表型。对未成熟的β选择后胸腺细胞母细胞进行TCR刺激会特异性地产生这个固有亚群,并在TCR库中固定早期T细胞受体α可变区(TRAV)和T细胞受体α连接区(TRAJ)重排。这些发现表明,在人类胸腺中,激动剂选择的检查点先于传统选择。